Asceneuron

0 followers


Asceneuron develops effective therapeutics for orphan tauopathies and Alzheimer’s disease.

Industries

+1

Headquarters

Employees

Links

Org chart

Barbara Angehrn Pavik
Chief Executive Officer

Barbara Angehrn Pavik

Collapse
Sandra Millet
Head Of Operations
Matthew Foy
Investor
Eric Yuen
Scientific Advisory Board Member
Hakan Goker
Board Director And Previous Acting CBO &observer
Andrin Cerletti
Head Of Business Development